Washington 2023-2024 Regular Session

Washington House Bill HB2029

Introduced
1/8/24  

Caption

Concerning opioid overdose reversal medication in high schools.

Impact

If enacted, HB2029 would mandate high schools to have access to opioid overdose reversal medications, such as naloxone, on their premises. This measure is designed to empower school officials and trained staff to act quickly in life-threatening situations, potentially saving lives during critical moments. The legislation is expected to influence existing health and safety protocols in schools, urging them to incorporate substance abuse response strategies into their emergency preparedness plans. Additionally, the bill signifies a shift towards integrating health education with emergency preparedness in school curriculums.

Summary

House Bill 2029 focuses on addressing the critical issue of opioid overdoses among students in high schools by facilitating the availability of opioid overdose reversal medication within these institutions. This legislation aims to equip schools with the necessary tools to respond effectively to opioid overdose incidents, thereby enhancing student safety and promoting a proactive approach to health emergencies related to substance abuse. The bill reflects a growing recognition of the opioid crisis and its impact on younger populations, emphasizing the need for preventive measures within educational settings.

Sentiment

The overall sentiment surrounding HB2029 appears to be supportive, particularly among health advocacy groups and educators who understand the urgency of addressing the opioid crisis among adolescents. Many proponents view the bill as a necessary step toward ensuring student health and safety, especially as the rates of opioid-related incidents among youth continue to rise. However, there may be concerns regarding the adequacy of training for school personnel and whether sufficient resources will be allocated to implement the bill effectively.

Contention

While the bill is largely accepted, notable points of contention may arise around the logistics of implementing medication availability in schools, including funding, training of staff to administer the medication, and the potential stigma associated with having opioid medications on school grounds. Some critics may voice concerns over the implications for young students' health education, questioning if the focus should pivot solely to harm reduction rather than preventative education on substance use.

Companion Bills

WA SB5804

Crossfiled Revised for 1st Substitute: Concerning opioid overdose reversal medication in public schools.Original: Concerning opioid overdose reversal medication in high schools.

Previously Filed As

WA SB5804

Revised for 1st Substitute: Concerning opioid overdose reversal medication in public schools.Original: Concerning opioid overdose reversal medication in high schools.

WA HB1413

Prohibiting government purchases of opioid overdose reversal medications from certain entities.

WA LB195

Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications

WA SB5229

Facilitating civil commitment for treatment for a person requiring revival by opioid overdose reversal medication.

WA SB6134

Preventing overdose and illicit use of opioids in Washington state.

WA HB2396

Concerning fentanyl and other synthetic opioids.

WA HB05053

An Act Concerning Opioids And Access To Overdose Reversal Drugs.

WA SB5240

Concerning anaphylaxis medications in schools.

WA HB2112

Concerning opioid and fentanyl prevention education and awareness at institutions of higher education.

WA HB1227

Opioid overdose reversal medication in schools.

Similar Bills

No similar bills found.